Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AZD-0780 by AstraZeneca for Cardiovascular Disease: Likelihood of Approval
AZD-0780 is under clinical development by AstraZeneca and currently in Phase I for Cardiovascular Disease. According to GlobalData, Phase I...
Risk adjusted net present value: What is the current valuation of AstraZeneca's AZD-0780?
AZD-0780 is a small molecule commercialized by AstraZeneca, with a leading Phase II program in Dyslipidemia. According to Globaldata, it...
AZD-0780 by AstraZeneca for Dyslipidemia: Likelihood of Approval
AZD-0780 is under clinical development by AstraZeneca and currently in Phase II for Dyslipidemia. According to GlobalData, Phase II drugs...
AZD-0780 by AstraZeneca for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia): Likelihood of Approval
AZD-0780 is under clinical development by AstraZeneca and currently in Phase I for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia). According to...